6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026

About

Imagion Biosystems Ltd (AU:IBX) — investor relations, events, news, and company updates on 6ix.

Latest News

FY25 Appendix 4E and Annual Report

Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent

IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial

Appendix 4C and Quarterly Activities Report - December 2025

Mercer Convertible Securities Conversion and Amendment

Recent Videos

Imagion Biosystems Limited. (CXA: IBX) (ASX: IBX)

Imagion Biosystems Limited. (CXA: IBX) (ASX: IBX)

Feb 25, 2026

Australian IBX can replace Biopsies #MagSense #IBX #investing #biotechnology

Australian IBX can replace Biopsies #MagSense #IBX #investing #biotechnology

Feb 11, 2026

Imagion Biosystems lodge FDA IND for MagSense HER2 Phase 2 trial

Imagion Biosystems lodge FDA IND for MagSense HER2 Phase 2 trial

Feb 11, 2026

Imagion Biosciences reach key FDA milestone for MagSense

Imagion Biosciences reach key FDA milestone for MagSense

Feb 03, 2026

Financials

Revenue

A$73.03 K

Market Cap

A$10.79 M

EPS

-0.02

Community Chat

Ask AI